Obama Inc. to Deny Cancer Treatments by Redefining What “Cancer” Is

Investment Watch Blog

The death panels aren’t going to come through the front door. They’re going to sneak up on you from behind with piano wire.

On July 29, 2013, a working group for the National Cancer Institute (the main government agency for cancer research) published a paper proposing that the term “cancer” be reserved for lesions with a reasonable likelihood of killing the patient if left untreated. Slower growing tumors would be called a different name such as “indolent lesions of epithelial origin” (IDLE).

Their justification was that modern medical technology now allows doctors to detect small, slow-growing tumors that likely wouldn’t be fatal. Yet once patients are told they have a cancer, many become frightened and seek unnecessary further tests, chemotherapy, radiation, and/or surgery.

By redefining the term “cancer,” the National Cancer Institute hopes to reduce patient anxiety and reduce the risks and expenses associated with supposedly unnecessary medical procedures. In technical terms, the government hopes to reduce “overdiagnosis” and “overtreatment” of cancer.

Related:   US employers slashing worker hours to avoid Obamacare insurance mandate
The IRS Wants to Be Exempt from Obamacare While also Being in Charge of Making the Rest of Us Comply

One thought on “Obama Inc. to Deny Cancer Treatments by Redefining What “Cancer” Is”

  1. Patients with cancer endure challenging symptoms resulting from the cancer itself
    or the side effects of conventional treatments. Through research our journey has
    led to an informed selection of complementary therapies that embody the intelligent
    pursuit of wellness. Click to purchase, read more about our complementary therapies,
    or review clinical support materials – See more at Cancer Treatment

Comments are closed.